Withdrawals due to adverse events · patients with pain management in rheumatoid arthritis
It is very uncertain whether tricyclic antidepressant changes number of Withdrawals due to Adverse Events patient interview compared with control (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · children with asymptomatic flat feet
It is very uncertain whether prefabricated foot orthoses changes withdrawal due to adverse events compared with shoes (very low certainty).
1 finding from 1 review
RR 0.99 [0.79, 1.23]
Studies not reported
Very low
Withdrawals due to adverse events · children with juvenile idiopathic arthritis and flat feet
Prefabricated foot orthoses showed no clear difference in withdrawal due to adverse events compared with shoes; GRADE not reported.
1 finding from 1 review
RR 0.72 [0.14, 3.61]
Studies not reported
GRADE not reported
Withdrawals due to adverse events · children with symptomatic flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · children with asymptomatic flat feet
Custom foot orthoses showed no clear difference in withdrawal due to adverse events compared with prefabricated foot orthoses (low certainty).
1 finding from 1 review
RR 1 [0.9, 1.12]
Studies not reported
Low
Withdrawals due to adverse events · children with juvenile idiopathic arthritis and flat feet
Custom foot orthoses showed no clear difference in withdrawal due to adverse events compared with prefabricated foot orthoses (low certainty).
1 finding from 1 review
RR 0.8 [0.13, 4.87]
Studies not reported
Low
Withdrawals due to adverse events · postmenopausal women with a higher risk for fracturesa
It is very uncertain whether intermittent/cyclic etidronate 400 mg/day changes withdrawals due to adverse events compared with placebo (very low certainty).
1 finding from 1 review
RR 1.09 [0.54, 2.18]
Studies not reported
Very low
Withdrawals due to adverse events · postmenopausal women at lower risk of fractures1
Intermittent/cyclic etidronate 400 mg/day showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).
1 finding from 1 review
RR 1.41 [0.81, 2.47]
Studies not reported
Low
Withdrawals due to adverse events · pPostmenopausal women at higher risk of fractures1
Risedronate 5 mg/day showed no clear difference in withdrawals due to adverse events compared with placebo (high certainty).
1 finding from 1 review
RR 0.98 [0.9, 1.07]
Studies not reported
High
Withdrawals due to adverse events · postmenopausal women at lower risk of fractures1
Risedronate 5 mg/day showed no clear difference in withdrawals due to adverse events compared with placebo (low certainty).
1 finding from 1 review
RR 0.67 [0.38, 1.18]
Studies not reported
Low